Hansa Biopharma to participate in LSX Congress USA in Boston
Lund, Sweden, September 21, 2026. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), today announced that Fredrik Röök, VP Business Development at Hansa Biopharma, will participate in the panel discussion “Breaking into New Markets: Strategies for Global Biopharma Expansion” at LSX Congress USA in Boston at 11:00 a.m. EST on Wednesday, September 23, 2026.
